| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.68 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |